Fig. 1. At year 7, the patient presented with a large, 7 cm right sided mass with extension to the right carotid artery (A). Lenvatinib treatment was initiated and despite some initial side effects, there was a marginal response (B, C). Unfortunately, surgical intervention was still not possible and dabrafenib/trametinib treatment was initiated. BRAF/MEK inhibition has a drastic response (D) allowing for surgical resection and RAI therapy.

Int J Thyroidol 2024;17:299-303 https://doi.org/10.11106/ijt.2024.17.2.299

© 2024 Int J Thyroidol